Oxidative Stress as a Trigger for Cellular Immune Responses in Patients with Alcoholic Liver Disease

Hepatology

Volumn 39, Issue 1, 2004, Pages 197-203

  Stewart, Stephen F ^a   Vidali, Matteo ^b   Day, Christopher P ^a   Albano, Emanuele ^b   Jones, David E J ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; HUMAN SERUM ALBUMIN; MALONALDEHYDE; OKT 3; THYMIDINE; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT; SERUM ALBUMIN;

ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIVISION; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; METABOLISM;

ACETALDEHYDE; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MALONDIALDEHYDE; MUROMONAB-CD3; OXIDATIVE STRESS; SERUM ALBUMIN;

EID: 1442281990     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20021     Document Type: Article

References (33)

1. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Croce L, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41:845-850.
2. Stewart S, Jones DEJ, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Molec Med 2001;7:408-413.
3. Ekstrom C, Ingehnan-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989;38:1313-1319.
4. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chemico-Biol Interact 1988;65:223-234.
5. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-724.
6. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. HEPATOLOGY 1994;20:453-460.
7. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-952.
8. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. HEPATOLOGY 2001;33:1148-1153.
9. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. HEPATOLOGY 1997;26:143-146.
10. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000;46:540-545.
11. Tuma DJ, Hoffman T, Sorrell MF. The chemistry of acetaldehyde-protein adducts. Alcohol Alcoholism 1991;1(Suppl):271-276.
12. Esterbauer H, Shaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal and malondialdehyde and related compounds. Free Rad Biol Med 1991;11:81-128.
13. Lin RC, Zhou FC, Fillenwarth MJ, Lumeng L. Zonal distribution of protein-acetaldehyde adducts in the liver of rats fed alcohol for long periods. HEPATOLOGY 1993;18:864-869.
14. Niemela O, Parkkila S, Yla-Herttuala S, Halsted C, Witztum JL, Lanca A, Israel Y. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994;70:537-546.
15. Viitala K, Israel Y, Blake JE, Niemela O. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption. HEPATOLOGY 1997;25:1418-1424.
16. Israel Y, Hurwitz E, Niemela O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci U S A 1986;83:7923-7927.
17. Viitala K, Makkonen K, Israel Y, Lehtimaki T, Jaakkola O, Koivula T, Blake JE, et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res 2000;24:1103-1109.
18. Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M, Vidali M, et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:38-45.
19. Clot P, Parola M, Bellomo G, Dianzani U, Carini R, Tabone M, Arico S, et al. Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 1997;113:265-276.
20. Chedid A, Mendenhall CL, Motitz TE, French SW, Chen TS, Morgan TR, Roselle GA, et al. Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology 1993;105:254-266.
21. Szabo G, Verma B, Catalano D. Selective inhibition of antigen-specific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production. J Leuk Biol 1993;54:534-544.
22. Cochrane AM, Moussouros A, Portmann B, McFarlane IG, Thomson AD, Eddleston, Williams R. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology 1977;72:918-923.
23. Izumi N, Hasumura Y, Takeuchi J. Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease. Clin Exp Immunol 1983;53:219-224.
24. Cederbaum AI. Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic Biol Med 1989;7:537-539.
25. Nordmann R, Ribiere C, Rouach H. Implications of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med 1992;12:219-240.
26. Tuma DJ. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic Biol Med 2002;32:303-308.
27. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:110-114.
28. Klassen KW, Tuma DJ, Sorrell MF. Immune mechanisms of alcohol-induced liver disease. HEPATOLOGY 1995;22:355-357.
29. Yamada S, Kumazawa S, Ishii T, Nakayama T, Itakura K, Shibata N, Kobayashi M, et al. Immunochemical detection of lipofuscin-like fluorophore derived from malondialdehyde and lysine. J Lipid Res 2001;1187-1196.
30. Rolla R, Vay D, Mottaran E, Parodi M, Traverso N, Arico S, Sartori M, et al. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. HEPATOLOGY 2000;31:878-884.
31. Colombat M, Charlotte F, Ratziu V, Poynard T. Portal lymphocytic infiltrate in alcoholic liver disease. Hum Pathol 2002;33:1170-1174.
32. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033-1036.
33. Mathurin P, Mendenhall CL, Carithers RL, Ramond M-J, Maddrey WC, Gartside P, Rueff B, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo-controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-487.